Procurement of Microbiological Tests

Deadline:10 Dec 2026, 11:00

Tender information
Скопски
Type
Contract
Procedure
Open procedure
Ref. number
19640/2026
Duration
30/03/2027 - 30/03/2028
Procurement of Microbiological Tests

101

Rapid rK39 immunochromatographic test for detection of Leishmania infection

102

Rapid test cassette for detection of IgM and IgG antibodies associated with filariasis

103

Kovács indole spot test or equivalent

104

Staphylococcus aureus ATCC 29213 or equivalent

105

Parasite concentration kit with 10% formalin and Triton X fixative, Midi Parasep or equivalent

106

Monovalent Shigella O antiserum

107

Polyvalent Shigella O antiserum

108

Treponema pallidum haemagglutination assay (TPHA) for syphilis

109

Urinary Legionella antigen test

110

Direct immunofluorescence microscopy test for Chlamydia trachomatis

111

Indirect immunofluorescence microscopy test for Leishmania IgM (5 × 10), with coded trays for 10-field indirect immunofluorescence biochip assays, or equivalent

112

Indirect immunofluorescence microscopy test for Leishmania IgG (5 × 10), with coded reagent trays for 10-field indirect immunofluorescence biochip assays, or equivalent

113

Indirect immunofluorescence microscopy test for Rickettsia IgG (5 × 10), with coded reagent trays for 10-field indirect immunofluorescence biochip assays, or equivalent

114

Indirect immunofluorescence microscopy test for Echinococcus IgG (5 × 10), with coded reagent trays for 10-field indirect immunofluorescence biochip assays, or equivalent

115

Indirect immunofluorescence microscopy test for Echinococcus IgM, with coded reagent trays for 10-field indirect immunofluorescence biochip assays, or equivalent

116

11-parameter urine test strips, pack of 100

117

Tween 20 additive for phosphate-buffered saline (PBS), premeasured for 1 L of solution, for indirect immunofluorescence test (IIFT) biochip systems

118

Venereal Disease Research Laboratory (VDRL) test for syphilis

119

VI Rapid Hydatidosis or equivalent immunochromatographic test for detection of antibodies against Echinococcus

120

Western blot test for detection of syphilis IgG antibodies

121

Western blot test for detection of syphilis IgM antibodies

122

Western blot test for IgG antibodies against Toxocara canis, including an update to compatible evaluation software or provision of a compatible scanner and software

123

Western blot test for IgG and IgM antibodies against Echinococcus, including evaluation software or provision of a compatible scanner and software

124

Antiserum against O antigen 11, group F (max. 3 mL)

125

Antiserum against O antigens 13 and 22, group G (max. 3 mL)

126

Antiserum against O antigens 3, 10, 15 and 19, group E (max. 3 mL)

127

Antiserum against O antigen 4, group B (max. 3 mL)

128

Antiserum against O antigens 6 and 7, group C1 (max. 3 mL)

129

Antiserum against O antigen 8, group C2 (max. 3 mL)

130

Antiserum against O antigen 9, group D (max. 3 mL)

131

Antiserum against O antigen “Vi” (max. 3 mL)

132

Antiserum against O antigens 4 and 12 (max. 3 mL)

133

Two-colour agglutination test for detection of antibodies against Entamoeba histolytica in serum, with controls included

134

Rapid Rose Bengal test for brucellosis (5 mL), with positive and negative controls and a minimum sensitivity of 25 ± 5 IU/mL

135

Bacteriological DNA test kit for E. coli O157, for immunomagnetic separation (100 reactions)

136

Rapid test for qualitative detection of Clostridium difficile glutamate dehydrogenase (GDH), toxin A and toxin B antigens in human stool

137

Rapid test for qualitative detection of Helicobacter pylori antigen in human stool

138

Type A microscopy immersion oil for a 100× oil-immersion objective

139

Species-specific indirect immunofluorescence microscopy test for Plasmodium falciparum, P. vivax and P. malariae, with coded reagent trays for 10-field indirect immunofluorescence biochip assays, or equivalent

140

Indirect haemagglutination test for quantitative detection of Distoma (Paragonium)

141

Indirect haemagglutination test for quantitative serological detection of Fasciola hepatica

142

Indirect haemagglutination test for quantitative serological diagnosis of Schistosoma infection

143

Indirect haemagglutination test for quantitative serological diagnosis of Trichinella spiralis infection

144

Slide incubation cuvettes for indirect immunofluorescence test (IIFT) biochip systems, for slides with 5–10 fields

145

Coded reagent trays for 10-field indirect immunofluorescence biochip assays

146

Phosphate-buffered saline (PBS), pH 7.2–7.4

147

Biological spore indicators for steam sterilisation monitoring (autoclaving), with culture medium and indicator

148

Biological spore indicators for dry-heat sterilisation monitoring, with culture medium and indicator

149

Indirect immunofluorescence test for detection of IgG and IgM. Each test comprises both IgG and IgM testing, in either a combined or separate format. See the technical specification for details.

150

Liquid immunosorbent for indirect immunofluorescence

151

Haemagglutination test for serological diagnosis of echinococcosis (Hydatidose Fumouze)

152

Amikacin disc, 30 µg

153

Amoxicillin, 10 µg

154

Ampicillin disc, 2 µg

155

Amoxicillin/clavulanic acid, 3 µg

156

Amoxicillin/clavulanic acid, 30 µg

157

Ampicillin, 10 µg

158

Ampicillin/sulbactam, 10/10 µg

159

Azithromycin, 15 µg

160

Aztreonam disc, 30 µg

161

Bacitracin, 10 µg

162

Cefadroxil, 30 µg

163

Cefepime, 30 µg

164

Cefepime/clavulanic acid, 30/10

165

Cefixime discs, 5 µg

166

Cefotaxime, 30 µg

167

Cefotaxime, 5 µg

168

Cefoxitin, 30 µg

169

Cefpodoxime discs, 10 µg

170

Ceftazidime, 10 µg

171

Ceftazidime discs, 30 µg

172

Ceftriaxone, 5 µg

173

Ceftriaxone discs, 30 µg

174

Cefuroxime discs, 30 µg

175

Chloramphenicol discs, 30 µg

176

Clarithromycin, 15 µg

177

Clindamycin discs, 2 µg

178

Cefaclor, 30 µg

179

Cefalexin, 30 µg

180

Cefalotin, 30 µg

181

Cefotaxime/clavulanic acid, 30/10 µg

182

Ceftaroline, 5 µg

183

Ceftazidime/clavulanic acid, 30/10 µg

184

Ceftazidime/avibactam, 10/4 µg

185

Ceftibuten, 30 µg

186

Ceftolozane/tazobactam, 30/10 µg

187

Ciprofloxacin, 5 µg

188

Co-trimoxazole, 25 µg

189

Doripenem, 10 µg

190

Ertapenem, 10 µg

191

Erythromycin (E), 15 µg

192

Fusidic acid, 10 µg

193

Fosfomycin, 200 µg

194

Gentamicin, 10 µg

195

Gentamicin, 30 µg

196

Imipenem discs, 10 µg

197

Levofloxacin, 5 µg

198

Linezolid, 10 µg

199

Lomefloxacin, 10 µg

200

Metronidazole, 5 µg

301

Cronobacter sakazakii ATCC 29544 or ATCC BAA-894

302

Escherichia coli O157 ATCC 43895

303

Enterococcus spp. ATCC 19433

Buyer
PHI Institute of Public Health of Republic of North Macedonia Skopje
buyer-email@mail.com
organization number
Open for offers
22 days left
Important dates
17 Nov - Publication date
10 Dec - Deadline
Unlock Full Access with Mercell Bidding Business Plus
Start your free trial to explore exclusive features that help you win more tenders, faster:
AI-Powered Tender Insights
Buyer Contact Info
Key Tender Timelines

Already have an account?